Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-267061
Filing Date
2025-11-05
Accepted
2025-11-05 16:31:01
Documents
76
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-20250930.htm   iXBRL 10-Q 3132243
2 EX-31.1 adpt-ex31_1.htm EX-31.1 19245
3 EX-31.2 adpt-ex31_2.htm EX-31.2 19239
4 EX-32.1 adpt-ex32_1.htm EX-32.1 11954
5 EX-32.2 adpt-ex32_2.htm EX-32.2 13347
  Complete submission text file 0001193125-25-267061.txt   11452830

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20250930.xsd EX-101.SCH 1179788
79 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20250930_htm.xml XML 2420105
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 251454552
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)